Biotech · Palo Alto, United States

Biogenesis

Biogenesis aims to transform clinical trials by decentralizing, automating, and speeding processes, removing logistical and administrative burdens. Its DRaaS model, powered by AI and novel systems, streamlines end-to-end drug development and enables researchers to focus on science.

Work at Biogenesis?

Location
Palo Alto, United States
Team size
1-10
Founded 2023
Total raised
$2.8M
Seed

About Biogenesis

Biogenesis is a company focused on transforming clinical trials by applying decentralization, automation, and speed. Its mission is to redefine the clinical trials landscape by removing logistical complexities and administrative burdens that hinder scientific work. The company envisions drug development and clinical trials transcending traditional constraints through its self-sufficient systems and aims to be the backbone of groundbreaking medical breakthroughs, including efforts toward a cancer cure. Biogenesis promotes a Drug Research as a Service (DRaaS) model powered by artificial intelligence and novel operational systems to streamline the entire drug development process, empowering individual researchers to manage end-to-end trial operations and enable scientists to devote their full attention to research and innovation.

Culture & values

Empowers individual researchers to manage end-to-end trial operations, signaling a culture of autonomy and ownership.

AI and novel operational systems are integral to the way work is performed, reflecting a tech-forward, data-driven culture.

Funding

$2.8Mtotal raised

Company at a glance

Founded2023
Location
Palo Alto, United States

The team at Biogenesis

1-10 peopleSee everyone on LinkedIn

Location

Life at Biogenesis

Frequently asked questions

Biogenesis is based in Palo Alto, United States.

Ask your AI about Biogenesis

Connect Clera once, then ask what they're hiring for.

Ask about this company

Tell me about Biogenesis (https://www.getclera.com/companies/biogenesis). Then find open roles at similar startups on Clera that fit my profile.
Not connected yet? Takes a minute
One click above pre-fills the connector. Or by hand: Settings > Connectors > Add custom connector, paste https://mcp.getclera.com. Either way, sign in with the account you use on Clera and approve the consent screen.
https://mcp.getclera.com

Sign in with your Clera account. MCP docs

Companies similar to Biogenesis

Afthonea

We’re building the first autonomous insurance group, starting with Morrow, our AI-native commercial insurance brokerage. We help businesses find, compare, and buy insurance across 100+ carriers. Every placement deepens our understanding of businesses, risk, and underwriting. We’re turning that knowledge into an insurance ontology that gives our AI agents the context to reason, apply judgment, and execute insurance workflows autonomously across calls, emails, and carrier portals. Our ambition is to build the most comprehensive intelligence layer in the industry. Over time, we’ll use this foundation to develop and underwrite our own insurance products. Insurance spending represents 12% of U.S. GDP, and we want to go after all of it. We’re backed by C-suite executives at some of the world’s largest insurers, first-check investors in Rippling and Twilio, and a Cloudflare board member. We're also a member of the YC W27 batch.

Insurance1-10
Aranya Inc.

Aranya builds ClusterdOS, a GitOps-native distributed operating system that makes production-grade Kubernetes infrastructure accessible to solo developers and small teams. ClusterdOS removes operational barriers to Kubernetes adoption, and no platform team is required when using it. Aranya also offers managed Kubernetes services for bare metal deployments.

Data & Infrastructure1-10
Avoltra (avoltra.io)

Based in Munich, Germany, Avoltra is an energy tech startup focused on helping energy-intensive industrial companies optimize their full energy lifecycle. The company describes its mission as building the operating system for how large industrial players manage energy, positioning itself as an early-stage player in the energy technology market. Avoltra serves industrial customers in the energy management space and requires on-site work. It is pre-seed funded and about one year old.

1-10